Human Papillomavirus and Uterine Cervical Carcinoma Risk Human Papillomavirus and Uterine Cervical Carcinoma Risk

Article Sidebar

PDF
Published: Aug 30, 2024
DOI: https://doi.org/10.58564/jmob.54
Keywords:
Human papillomavirus, HPV16-like, UCC, viral oncoproteins.

Main Article Content

Alyaa Jabbar Qasim
Iraqi center of cancer and medical genetic research, Baghdad, Iraq
Ayat Majeed Zeadan
Microbiology department/ College of medicine/Aliraqia University, Baghdad, Iraq.
https://orcid.org/0009-0002-0496-9401
Sura Mouaid Abbas
Department of biology, College of science/Al-Mustansiriyah university, Baghdad, Iraq

Abstract

Abstract 


Uterine Cervical Carcinoma (UCC) is the most common gynecological malignancy internationally, with a rising incidence in recent years. Accumulating data indicates that specific viral infections, especially that are caused by oncogenic viruses including Epstein-Barr virus (EBV) that may contribute to UCC development in addition to progression. Understanding the complex interplay between EBV infections and UCC risk is crucial for developing novel preventative and therapeutic interventions. Therefore, this review study focuses on the human papillomavirus (HPV) infection and the etiology of Uterine Cervical Carcinoma.


Keywords: Human papillomavirus, HPV16-like, UCC, viral oncoproteins.

Article Details

How to Cite
Qasim , A. J., Zeadan, A. M., & Sura Mouaid Abbas , S. M. A. (2024). Human Papillomavirus and Uterine Cervical Carcinoma Risk: Human Papillomavirus and Uterine Cervical Carcinoma Risk. Journal of Medical and Oral Biosciences ( JMOB), 1(3), 52–59. https://doi.org/10.58564/jmob.54
Issue
Vol. 1 No. 3 (2024): Vol.1.(No.3).2024
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

The Journal of Medical and Oral Biosciences uses a Creative Commons Attribution (CC Attribution-ShareAlike 4.0) and its license of (CC BY-SA 4.0). This license allows the authors to hold ownership of the copyright of their articles.

Attribution-Share Alike 4.0 International License (CC BY-SA 4.0). 

Under the CC BY-SA 4.0 the authors are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
No use, distribution or reproduction is permitted which does not comply with these terms.
https://creativecommons.org/licenses/by-sa/4.0/

https://creativecommons.org/licenses/by-sa/4.0/